| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,854,000 | 1,920,000 | 1,799,000 | 1,980,000 | | Cost of Revenue | 1,014,000 | (3,432,000) | 3,432,000 |
-
| | | Gross Profit | 840,000 | 5,352,000 | (1,633,000) | 1,980,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 397,000 | 5,031,000 | (1,914,000) | 1,667,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 60,000 | 65,000 | 49,000 | 58,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 383,000 | 256,000 | 232,000 | 255,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,000) | (48,000) | 3,000 | 2,000 | | Earnings Before Interest And Taxes | 372,000 | 208,000 | 235,000 | 257,000 | | Interest Expense | 29,000 | 30,000 | 32,000 | 31,000 | | Income Before Tax | 343,000 | 178,000 | 203,000 | 226,000 | | Income Tax Expense | 108,000 | 51,000 | 56,000 | 58,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 235,000 | 127,000 | 147,000 | 168,000 | | | Non-recurring Events | | Discontinued Operations | 50,000 | (133,000) | (30,000) | 965,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 285,000 | (6,000) | 117,000 | 1,133,000 | | Preferred Stock And Other Adjustments | (5,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $280,000 | ($6,000) | $117,000 | $1,133,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
